Gland Pharma Limited (BOM:543245)

Gland Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	282,574	262,358	303,932	208,882	537,705	405,432
Market Cap Growth	-1.88%	-13.68%	45.50%	-61.15%	32.63%	-
Enterprise Value	253,578	236,321	286,055	175,977	508,469	390,204
Last Close Price	1715.25	1577.51	1806.28	1244.07	3205.93	2429.88
PE Ratio	35.75	37.56	39.35	26.74	44.38	40.67
PS Ratio	4.87	4.67	5.37	5.76	12.22	11.71
PB Ratio	2.95	2.87	3.48	2.63	7.51	6.87
P/TBV Ratio	3.08	2.98	3.63	2.63	7.53	6.87
P/FCF Ratio	63.79	49.48	50.08	146.03	192.42	107.78
P/OCF Ratio	32.69	28.68	30.49	57.39	68.00	67.02
EV/Sales Ratio	4.37	4.21	5.05	4.86	11.55	11.27
EV/EBITDA Ratio	18.51	19.19	22.06	17.07	33.67	29.97
EV/EBIT Ratio	26.12	27.10	29.45	19.90	36.32	32.42
EV/FCF Ratio	57.25	44.57	47.14	123.03	181.96	103.74
Debt / Equity Ratio	0.03	0.03	0.04	0.00	0.00	0.00
Debt / EBITDA Ratio	0.22	0.25	0.28	0.00	0.00	0.00
Debt / FCF Ratio	0.68	0.59	0.61	0.03	0.02	0.01
Asset Turnover	0.51	0.51	0.58	0.44	0.61	0.65
Inventory Turnover	1.42	1.44	1.40	1.16	1.79	1.56
Quick Ratio	2.79	3.01	2.61	6.58	7.80	7.31
Current Ratio	4.13	4.34	4.04	9.46	10.06	10.00
Return on Equity (ROE)	8.61%	7.82%	9.26%	10.33%	18.55%	20.88%
Return on Assets (ROA)	5.35%	4.98%	6.25%	6.65%	12.21%	14.22%
Return on Capital (ROIC)	6.39%	5.87%	7.12%	7.31%	13.39%	15.73%
Return on Capital Employed (ROCE)	9.60%	9.00%	10.50%	11.00%	19.30%	20.10%
Earnings Yield	2.80%	2.66%	2.54%	3.74%	2.25%	2.46%
FCF Yield	1.57%	2.02%	2.00%	0.69%	0.52%	0.93%
Dividend Yield	1.09%	1.14%	1.11%	-	-	-
Payout Ratio	37.52%	47.17%	-	-	-	-
Buyback Yield / Dilution	0.01%	-0.01%	-0.03%	-0.09%	-3.96%	-2.15%
Total Shareholder Return	1.09%	1.13%	1.07%	-0.09%	-3.96%	-2.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.